nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—Hyperaemia—Carmustine—malignant glioma	0.0381	0.0566	CcSEcCtD
Brinzolamide—Visual acuity reduced—Temozolomide—malignant glioma	0.0187	0.0278	CcSEcCtD
Brinzolamide—Digestion impaired—Temozolomide—malignant glioma	0.0166	0.0247	CcSEcCtD
Brinzolamide—Apathy—Temozolomide—malignant glioma	0.0156	0.0231	CcSEcCtD
Brinzolamide—Flat affect—Temozolomide—malignant glioma	0.0154	0.0229	CcSEcCtD
Brinzolamide—Memory impairment—Temozolomide—malignant glioma	0.0142	0.0211	CcSEcCtD
Brinzolamide—CA14—telencephalon—malignant glioma	0.0137	0.0584	CbGeAlD
Brinzolamide—CA7—midbrain—malignant glioma	0.0118	0.0503	CbGeAlD
Brinzolamide—CA14—medulla oblongata—malignant glioma	0.0107	0.0459	CbGeAlD
Brinzolamide—CA12—telencephalon—malignant glioma	0.0107	0.0455	CbGeAlD
Brinzolamide—Dry eye—Temozolomide—malignant glioma	0.0103	0.0153	CcSEcCtD
Brinzolamide—Abnormal vision—Carmustine—malignant glioma	0.01	0.0149	CcSEcCtD
Brinzolamide—CA14—midbrain—malignant glioma	0.00982	0.0419	CbGeAlD
Brinzolamide—Abnormal vision—Temozolomide—malignant glioma	0.0097	0.0144	CcSEcCtD
Brinzolamide—CA14—spinal cord—malignant glioma	0.00958	0.0409	CbGeAlD
Brinzolamide—Eye pain—Carmustine—malignant glioma	0.00925	0.0138	CcSEcCtD
Brinzolamide—CA7—cerebellum—malignant glioma	0.00912	0.0389	CbGeAlD
Brinzolamide—Eye pain—Temozolomide—malignant glioma	0.00894	0.0133	CcSEcCtD
Brinzolamide—Amnesia—Carmustine—malignant glioma	0.00889	0.0132	CcSEcCtD
Brinzolamide—Nasal congestion—Temozolomide—malignant glioma	0.00886	0.0132	CcSEcCtD
Brinzolamide—Amnesia—Temozolomide—malignant glioma	0.00859	0.0128	CcSEcCtD
Brinzolamide—CA1—telencephalon—malignant glioma	0.00845	0.0361	CbGeAlD
Brinzolamide—Diplopia—Carmustine—malignant glioma	0.00835	0.0124	CcSEcCtD
Brinzolamide—Diplopia—Temozolomide—malignant glioma	0.00807	0.012	CcSEcCtD
Brinzolamide—CA9—cerebellum—malignant glioma	0.00801	0.0342	CbGeAlD
Brinzolamide—Liver function test abnormal—Carmustine—malignant glioma	0.00771	0.0115	CcSEcCtD
Brinzolamide—CA14—cerebellum—malignant glioma	0.0076	0.0324	CbGeAlD
Brinzolamide—CA4—brainstem—malignant glioma	0.00744	0.0318	CbGeAlD
Brinzolamide—CA7—brain—malignant glioma	0.00741	0.0316	CbGeAlD
Brinzolamide—Breast disorder—Temozolomide—malignant glioma	0.00729	0.0108	CcSEcCtD
Brinzolamide—CA2—embryo—malignant glioma	0.00673	0.0287	CbGeAlD
Brinzolamide—Bronchitis—Temozolomide—malignant glioma	0.00671	0.00998	CcSEcCtD
Brinzolamide—CA4—telencephalon—malignant glioma	0.0066	0.0282	CbGeAlD
Brinzolamide—Pollakiuria—Temozolomide—malignant glioma	0.00644	0.00958	CcSEcCtD
Brinzolamide—Erectile dysfunction—Temozolomide—malignant glioma	0.00643	0.00955	CcSEcCtD
Brinzolamide—Depression—Carmustine—malignant glioma	0.00642	0.00954	CcSEcCtD
Brinzolamide—Infestation—Temozolomide—malignant glioma	0.00622	0.00925	CcSEcCtD
Brinzolamide—Infestation NOS—Temozolomide—malignant glioma	0.00622	0.00925	CcSEcCtD
Brinzolamide—Depression—Temozolomide—malignant glioma	0.0062	0.00922	CcSEcCtD
Brinzolamide—CA14—brain—malignant glioma	0.00617	0.0263	CbGeAlD
Brinzolamide—CA2—brainstem—malignant glioma	0.00617	0.0263	CbGeAlD
Brinzolamide—CA12—central nervous system—malignant glioma	0.00606	0.0259	CbGeAlD
Brinzolamide—CA2—retina—malignant glioma	0.00595	0.0254	CbGeAlD
Brinzolamide—CA1—spinal cord—malignant glioma	0.00592	0.0253	CbGeAlD
Brinzolamide—Hepatobiliary disease—Temozolomide—malignant glioma	0.00588	0.00875	CcSEcCtD
Brinzolamide—Sinusitis—Temozolomide—malignant glioma	0.00584	0.00868	CcSEcCtD
Brinzolamide—Hypoaesthesia—Carmustine—malignant glioma	0.00575	0.00855	CcSEcCtD
Brinzolamide—Oedema peripheral—Carmustine—malignant glioma	0.00569	0.00846	CcSEcCtD
Brinzolamide—Connective tissue disorder—Carmustine—malignant glioma	0.00568	0.00844	CcSEcCtD
Brinzolamide—Visual impairment—Carmustine—malignant glioma	0.00557	0.00828	CcSEcCtD
Brinzolamide—Hypoaesthesia—Temozolomide—malignant glioma	0.00556	0.00826	CcSEcCtD
Brinzolamide—Pharyngitis—Temozolomide—malignant glioma	0.00554	0.00824	CcSEcCtD
Brinzolamide—Urinary tract disorder—Temozolomide—malignant glioma	0.00551	0.0082	CcSEcCtD
Brinzolamide—Oedema peripheral—Temozolomide—malignant glioma	0.0055	0.00818	CcSEcCtD
Brinzolamide—Connective tissue disorder—Temozolomide—malignant glioma	0.00549	0.00816	CcSEcCtD
Brinzolamide—CA2—telencephalon—malignant glioma	0.00548	0.0234	CbGeAlD
Brinzolamide—Urethral disorder—Temozolomide—malignant glioma	0.00547	0.00814	CcSEcCtD
Brinzolamide—CA5B—central nervous system—malignant glioma	0.00544	0.0232	CbGeAlD
Brinzolamide—Eye disorder—Carmustine—malignant glioma	0.0054	0.00803	CcSEcCtD
Brinzolamide—Visual impairment—Temozolomide—malignant glioma	0.00538	0.008	CcSEcCtD
Brinzolamide—Eye disorder—Temozolomide—malignant glioma	0.00522	0.00776	CcSEcCtD
Brinzolamide—Tinnitus—Temozolomide—malignant glioma	0.00521	0.00774	CcSEcCtD
Brinzolamide—CA4—medulla oblongata—malignant glioma	0.00519	0.0222	CbGeAlD
Brinzolamide—Cardiac disorder—Temozolomide—malignant glioma	0.00518	0.0077	CcSEcCtD
Brinzolamide—Arrhythmia—Carmustine—malignant glioma	0.00516	0.00767	CcSEcCtD
Brinzolamide—Alopecia—Carmustine—malignant glioma	0.00511	0.00759	CcSEcCtD
Brinzolamide—Angiopathy—Temozolomide—malignant glioma	0.00507	0.00753	CcSEcCtD
Brinzolamide—Mental disorder—Carmustine—malignant glioma	0.00506	0.00753	CcSEcCtD
Brinzolamide—Immune system disorder—Temozolomide—malignant glioma	0.00504	0.0075	CcSEcCtD
Brinzolamide—Mediastinal disorder—Temozolomide—malignant glioma	0.00503	0.00748	CcSEcCtD
Brinzolamide—Erythema—Carmustine—malignant glioma	0.00503	0.00748	CcSEcCtD
Brinzolamide—Malnutrition—Carmustine—malignant glioma	0.00503	0.00748	CcSEcCtD
Brinzolamide—Alopecia—Temozolomide—malignant glioma	0.00493	0.00734	CcSEcCtD
Brinzolamide—Mental disorder—Temozolomide—malignant glioma	0.00489	0.00727	CcSEcCtD
Brinzolamide—Back pain—Carmustine—malignant glioma	0.00487	0.00723	CcSEcCtD
Brinzolamide—Erythema—Temozolomide—malignant glioma	0.00486	0.00723	CcSEcCtD
Brinzolamide—Malnutrition—Temozolomide—malignant glioma	0.00486	0.00723	CcSEcCtD
Brinzolamide—CA12—brain—malignant glioma	0.00481	0.0205	CbGeAlD
Brinzolamide—CA1—central nervous system—malignant glioma	0.0048	0.0205	CbGeAlD
Brinzolamide—Dysgeusia—Temozolomide—malignant glioma	0.00476	0.00708	CcSEcCtD
Brinzolamide—CA4—midbrain—malignant glioma	0.00474	0.0202	CbGeAlD
Brinzolamide—Vision blurred—Carmustine—malignant glioma	0.00474	0.00705	CcSEcCtD
Brinzolamide—Tremor—Carmustine—malignant glioma	0.00471	0.00701	CcSEcCtD
Brinzolamide—Back pain—Temozolomide—malignant glioma	0.0047	0.00699	CcSEcCtD
Brinzolamide—CA4—spinal cord—malignant glioma	0.00463	0.0198	CbGeAlD
Brinzolamide—Agitation—Carmustine—malignant glioma	0.00462	0.00687	CcSEcCtD
Brinzolamide—Vision blurred—Temozolomide—malignant glioma	0.00458	0.00681	CcSEcCtD
Brinzolamide—Tremor—Temozolomide—malignant glioma	0.00455	0.00677	CcSEcCtD
Brinzolamide—Ill-defined disorder—Temozolomide—malignant glioma	0.00451	0.00671	CcSEcCtD
Brinzolamide—Agitation—Temozolomide—malignant glioma	0.00447	0.00664	CcSEcCtD
Brinzolamide—Malaise—Temozolomide—malignant glioma	0.00438	0.00652	CcSEcCtD
Brinzolamide—Vertigo—Temozolomide—malignant glioma	0.00437	0.00649	CcSEcCtD
Brinzolamide—Hypertension—Carmustine—malignant glioma	0.00434	0.00646	CcSEcCtD
Brinzolamide—CA5B—brain—malignant glioma	0.00432	0.0184	CbGeAlD
Brinzolamide—CA2—medulla oblongata—malignant glioma	0.0043	0.0184	CbGeAlD
Brinzolamide—Palpitations—Temozolomide—malignant glioma	0.0043	0.00639	CcSEcCtD
Brinzolamide—Myalgia—Carmustine—malignant glioma	0.00428	0.00637	CcSEcCtD
Brinzolamide—Chest pain—Carmustine—malignant glioma	0.00428	0.00637	CcSEcCtD
Brinzolamide—Cough—Temozolomide—malignant glioma	0.00424	0.00631	CcSEcCtD
Brinzolamide—Hypertension—Temozolomide—malignant glioma	0.0042	0.00624	CcSEcCtD
Brinzolamide—Myalgia—Temozolomide—malignant glioma	0.00414	0.00615	CcSEcCtD
Brinzolamide—Arthralgia—Temozolomide—malignant glioma	0.00414	0.00615	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00411	0.00611	CcSEcCtD
Brinzolamide—Discomfort—Temozolomide—malignant glioma	0.00409	0.00608	CcSEcCtD
Brinzolamide—Infection—Carmustine—malignant glioma	0.00408	0.00606	CcSEcCtD
Brinzolamide—Dry mouth—Temozolomide—malignant glioma	0.00405	0.00602	CcSEcCtD
Brinzolamide—Tachycardia—Carmustine—malignant glioma	0.00401	0.00596	CcSEcCtD
Brinzolamide—Infection—Temozolomide—malignant glioma	0.00394	0.00586	CcSEcCtD
Brinzolamide—CA2—midbrain—malignant glioma	0.00393	0.0168	CbGeAlD
Brinzolamide—Nervous system disorder—Temozolomide—malignant glioma	0.00389	0.00578	CcSEcCtD
Brinzolamide—Skin disorder—Temozolomide—malignant glioma	0.00385	0.00573	CcSEcCtD
Brinzolamide—CA2—spinal cord—malignant glioma	0.00384	0.0164	CbGeAlD
Brinzolamide—Hypotension—Carmustine—malignant glioma	0.00384	0.0057	CcSEcCtD
Brinzolamide—CA1—brain—malignant glioma	0.00381	0.0163	CbGeAlD
Brinzolamide—CA4—central nervous system—malignant glioma	0.00375	0.016	CbGeAlD
Brinzolamide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00374	0.00556	CcSEcCtD
Brinzolamide—Insomnia—Carmustine—malignant glioma	0.00371	0.00552	CcSEcCtD
Brinzolamide—Paraesthesia—Carmustine—malignant glioma	0.00369	0.00548	CcSEcCtD
Brinzolamide—CA4—cerebellum—malignant glioma	0.00367	0.0157	CbGeAlD
Brinzolamide—Dyspnoea—Carmustine—malignant glioma	0.00366	0.00544	CcSEcCtD
Brinzolamide—Somnolence—Carmustine—malignant glioma	0.00365	0.00543	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00361	0.00537	CcSEcCtD
Brinzolamide—Insomnia—Temozolomide—malignant glioma	0.00359	0.00533	CcSEcCtD
Brinzolamide—Decreased appetite—Carmustine—malignant glioma	0.00357	0.00531	CcSEcCtD
Brinzolamide—Paraesthesia—Temozolomide—malignant glioma	0.00356	0.0053	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Carmustine—malignant glioma	0.00354	0.00527	CcSEcCtD
Brinzolamide—Dyspnoea—Temozolomide—malignant glioma	0.00354	0.00526	CcSEcCtD
Brinzolamide—Somnolence—Temozolomide—malignant glioma	0.00353	0.00524	CcSEcCtD
Brinzolamide—Pain—Carmustine—malignant glioma	0.00351	0.00522	CcSEcCtD
Brinzolamide—Dyspepsia—Temozolomide—malignant glioma	0.00349	0.00519	CcSEcCtD
Brinzolamide—Decreased appetite—Temozolomide—malignant glioma	0.00345	0.00513	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00343	0.00509	CcSEcCtD
Brinzolamide—Fatigue—Temozolomide—malignant glioma	0.00342	0.00509	CcSEcCtD
Brinzolamide—Pain—Temozolomide—malignant glioma	0.00339	0.00504	CcSEcCtD
Brinzolamide—Feeling abnormal—Carmustine—malignant glioma	0.00338	0.00503	CcSEcCtD
Brinzolamide—Feeling abnormal—Temozolomide—malignant glioma	0.00327	0.00486	CcSEcCtD
Brinzolamide—Urticaria—Temozolomide—malignant glioma	0.00315	0.00469	CcSEcCtD
Brinzolamide—CA2—central nervous system—malignant glioma	0.00311	0.0133	CbGeAlD
Brinzolamide—CA2—cerebellum—malignant glioma	0.00304	0.013	CbGeAlD
Brinzolamide—Hypersensitivity—Carmustine—malignant glioma	0.00302	0.0045	CcSEcCtD
Brinzolamide—CA4—brain—malignant glioma	0.00298	0.0127	CbGeAlD
Brinzolamide—Asthenia—Carmustine—malignant glioma	0.00295	0.00438	CcSEcCtD
Brinzolamide—Hypersensitivity—Temozolomide—malignant glioma	0.00292	0.00435	CcSEcCtD
Brinzolamide—Asthenia—Temozolomide—malignant glioma	0.00285	0.00423	CcSEcCtD
Brinzolamide—Diarrhoea—Carmustine—malignant glioma	0.00281	0.00418	CcSEcCtD
Brinzolamide—Pruritus—Temozolomide—malignant glioma	0.00281	0.00417	CcSEcCtD
Brinzolamide—Dizziness—Carmustine—malignant glioma	0.00271	0.00404	CcSEcCtD
Brinzolamide—Diarrhoea—Temozolomide—malignant glioma	0.00271	0.00404	CcSEcCtD
Brinzolamide—Dizziness—Temozolomide—malignant glioma	0.00262	0.0039	CcSEcCtD
Brinzolamide—Vomiting—Carmustine—malignant glioma	0.00261	0.00388	CcSEcCtD
Brinzolamide—Rash—Carmustine—malignant glioma	0.00259	0.00385	CcSEcCtD
Brinzolamide—Dermatitis—Carmustine—malignant glioma	0.00259	0.00384	CcSEcCtD
Brinzolamide—Headache—Carmustine—malignant glioma	0.00257	0.00382	CcSEcCtD
Brinzolamide—Vomiting—Temozolomide—malignant glioma	0.00252	0.00375	CcSEcCtD
Brinzolamide—Rash—Temozolomide—malignant glioma	0.0025	0.00372	CcSEcCtD
Brinzolamide—Dermatitis—Temozolomide—malignant glioma	0.0025	0.00372	CcSEcCtD
Brinzolamide—Headache—Temozolomide—malignant glioma	0.00249	0.0037	CcSEcCtD
Brinzolamide—CA2—brain—malignant glioma	0.00247	0.0106	CbGeAlD
Brinzolamide—Nausea—Carmustine—malignant glioma	0.00244	0.00363	CcSEcCtD
Brinzolamide—Nausea—Temozolomide—malignant glioma	0.00236	0.0035	CcSEcCtD
Brinzolamide—CYP3A4—central nervous system—malignant glioma	0.00201	0.00857	CbGeAlD
Brinzolamide—CA6—Metabolism—IDH1—malignant glioma	0.000284	0.00305	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—IDH1—malignant glioma	0.000284	0.00305	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—BCAN—malignant glioma	0.000283	0.00304	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—SPHK1—malignant glioma	0.000282	0.00303	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000278	0.00299	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP2C18—malignant glioma	0.000276	0.00297	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ASMT—malignant glioma	0.000276	0.00297	CbGpPWpGaD
Brinzolamide—CA9—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000276	0.00296	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—SPHK1—malignant glioma	0.000275	0.00295	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—SPHK1—malignant glioma	0.000275	0.00295	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—BCAN—malignant glioma	0.000271	0.00291	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—HIF1A—malignant glioma	0.00027	0.0029	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP2C18—malignant glioma	0.000269	0.00289	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP2C18—malignant glioma	0.000269	0.00289	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP2B6—malignant glioma	0.000269	0.00288	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—IDH1—malignant glioma	0.000265	0.00285	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—IDH1—malignant glioma	0.000265	0.00285	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—BCAN—malignant glioma	0.00026	0.00279	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—SPHK1—malignant glioma	0.000257	0.00276	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—SPHK1—malignant glioma	0.000257	0.00276	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP2C18—malignant glioma	0.000251	0.0027	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP2C18—malignant glioma	0.000251	0.0027	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—IDH1—malignant glioma	0.000246	0.00264	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ASMT—malignant glioma	0.000243	0.00261	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—SPHK1—malignant glioma	0.000238	0.00255	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP2C18—malignant glioma	0.000233	0.0025	CbGpPWpGaD
Brinzolamide—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000231	0.00249	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—BCAN—malignant glioma	0.000228	0.00245	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—IDH2—malignant glioma	0.000228	0.00245	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTT1—malignant glioma	0.000223	0.0024	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—IDH2—malignant glioma	0.000218	0.00235	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTT1—malignant glioma	0.000218	0.00234	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTT1—malignant glioma	0.000218	0.00234	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP2B6—malignant glioma	0.000214	0.0023	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000211	0.00226	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS1—malignant glioma	0.000209	0.00225	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—IDH2—malignant glioma	0.000209	0.00225	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP2B6—malignant glioma	0.000205	0.00221	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS1—malignant glioma	0.000204	0.00219	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS1—malignant glioma	0.000204	0.00219	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTT1—malignant glioma	0.000203	0.00218	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTT1—malignant glioma	0.000203	0.00218	CbGpPWpGaD
Brinzolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.0002	0.00214	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP2B6—malignant glioma	0.000197	0.00211	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—IDH1—malignant glioma	0.000196	0.0021	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—BCHE—malignant glioma	0.000195	0.00209	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CDKN2A—malignant glioma	0.000193	0.00208	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—SLC5A5—malignant glioma	0.000192	0.00207	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS1—malignant glioma	0.000191	0.00205	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS1—malignant glioma	0.000191	0.00205	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—BCHE—malignant glioma	0.00019	0.00204	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—BCHE—malignant glioma	0.00019	0.00204	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—SPHK1—malignant glioma	0.00019	0.00204	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTT1—malignant glioma	0.000188	0.00202	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—IDH1—malignant glioma	0.000188	0.00202	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—MDM2—malignant glioma	0.000188	0.00202	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—SLC5A5—malignant glioma	0.000187	0.00201	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—SLC5A5—malignant glioma	0.000187	0.00201	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP2C18—malignant glioma	0.000186	0.00199	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—IDH2—malignant glioma	0.000184	0.00198	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—SPHK1—malignant glioma	0.000182	0.00195	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—IDH1—malignant glioma	0.00018	0.00193	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP2C18—malignant glioma	0.000178	0.00191	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—BCHE—malignant glioma	0.000177	0.0019	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—BCHE—malignant glioma	0.000177	0.0019	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS1—malignant glioma	0.000177	0.0019	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CXCL8—malignant glioma	0.000175	0.00188	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—SLC5A5—malignant glioma	0.000175	0.00188	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—SLC5A5—malignant glioma	0.000175	0.00188	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—SPHK1—malignant glioma	0.000174	0.00187	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP2B6—malignant glioma	0.000173	0.00186	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP2C18—malignant glioma	0.000171	0.00183	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.00017	0.00183	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000168	0.0018	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—BCHE—malignant glioma	0.000164	0.00176	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—SLC5A5—malignant glioma	0.000162	0.00174	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—IDH1—malignant glioma	0.000158	0.0017	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTP1—malignant glioma	0.000155	0.00166	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SPHK1—malignant glioma	0.000153	0.00165	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTP1—malignant glioma	0.000151	0.00162	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTP1—malignant glioma	0.000151	0.00162	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CAT—malignant glioma	0.000151	0.00162	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTT1—malignant glioma	0.00015	0.00161	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP2C18—malignant glioma	0.00015	0.00161	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000148	0.00159	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CAT—malignant glioma	0.000147	0.00158	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CAT—malignant glioma	0.000147	0.00158	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000146	0.00156	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTT1—malignant glioma	0.000144	0.00155	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—VEGFA—malignant glioma	0.000143	0.00153	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—NCOR1—malignant glioma	0.000142	0.00153	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—STAT3—malignant glioma	0.000141	0.00152	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTP1—malignant glioma	0.000141	0.00151	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTP1—malignant glioma	0.000141	0.00151	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS1—malignant glioma	0.000141	0.00151	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NCOR1—malignant glioma	0.000139	0.00149	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NCOR1—malignant glioma	0.000139	0.00149	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTT1—malignant glioma	0.000138	0.00148	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CAT—malignant glioma	0.000137	0.00147	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CAT—malignant glioma	0.000137	0.00147	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS1—malignant glioma	0.000135	0.00145	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—BCHE—malignant glioma	0.000131	0.00141	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTP1—malignant glioma	0.000131	0.0014	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—NCOR1—malignant glioma	0.00013	0.00139	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—NCOR1—malignant glioma	0.00013	0.00139	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS1—malignant glioma	0.000129	0.00139	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—SLC5A5—malignant glioma	0.000129	0.00139	CbGpPWpGaD
Brinzolamide—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000128	0.00137	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CAT—malignant glioma	0.000127	0.00136	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—BCHE—malignant glioma	0.000125	0.00135	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—SLC5A5—malignant glioma	0.000124	0.00133	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTT1—malignant glioma	0.000121	0.0013	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—BCHE—malignant glioma	0.00012	0.00129	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—NCOR1—malignant glioma	0.00012	0.00129	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000119	0.00128	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—SLC5A5—malignant glioma	0.000119	0.00128	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CAV1—malignant glioma	0.000116	0.00125	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS1—malignant glioma	0.000114	0.00122	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CAV1—malignant glioma	0.000113	0.00121	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CAV1—malignant glioma	0.000113	0.00121	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000112	0.0012	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—TP53—malignant glioma	0.000108	0.00116	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—BCHE—malignant glioma	0.000106	0.00114	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CG—malignant glioma	0.000106	0.00114	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CAV1—malignant glioma	0.000106	0.00113	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CAV1—malignant glioma	0.000106	0.00113	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SLC5A5—malignant glioma	0.000104	0.00112	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTP1—malignant glioma	0.000104	0.00112	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CG—malignant glioma	0.000103	0.00111	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CG—malignant glioma	0.000103	0.00111	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PPARG—malignant glioma	0.000102	0.0011	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CAT—malignant glioma	0.000101	0.00109	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTP1—malignant glioma	9.98e-05	0.00107	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PPARG—malignant glioma	9.94e-05	0.00107	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PPARG—malignant glioma	9.94e-05	0.00107	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CAV1—malignant glioma	9.78e-05	0.00105	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CAT—malignant glioma	9.71e-05	0.00104	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CG—malignant glioma	9.62e-05	0.00103	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CG—malignant glioma	9.62e-05	0.00103	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTP1—malignant glioma	9.57e-05	0.00103	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NCOR1—malignant glioma	9.57e-05	0.00103	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CAT—malignant glioma	9.31e-05	0.001	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CD—malignant glioma	9.29e-05	0.000998	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PPARG—malignant glioma	9.28e-05	0.000997	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PPARG—malignant glioma	9.28e-05	0.000997	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NCOR1—malignant glioma	9.17e-05	0.000985	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CD—malignant glioma	9.06e-05	0.000972	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CD—malignant glioma	9.06e-05	0.000972	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CG—malignant glioma	8.91e-05	0.000957	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NCOR1—malignant glioma	8.79e-05	0.000944	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PPARG—malignant glioma	8.6e-05	0.000923	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CD—malignant glioma	8.45e-05	0.000908	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CD—malignant glioma	8.45e-05	0.000908	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTP1—malignant glioma	8.41e-05	0.000903	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—RTEL1—malignant glioma	8.37e-05	0.000899	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTP1—malignant glioma	8.28e-05	0.000889	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CAT—malignant glioma	8.19e-05	0.000879	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	8.17e-05	0.000877	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CB—malignant glioma	8.1e-05	0.00087	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS2—malignant glioma	8.03e-05	0.000862	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CB—malignant glioma	7.89e-05	0.000848	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CB—malignant glioma	7.89e-05	0.000848	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CD—malignant glioma	7.83e-05	0.000841	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS2—malignant glioma	7.82e-05	0.00084	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS2—malignant glioma	7.82e-05	0.00084	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CAV1—malignant glioma	7.8e-05	0.000838	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NCOR1—malignant glioma	7.73e-05	0.00083	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CAV1—malignant glioma	7.48e-05	0.000803	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CB—malignant glioma	7.37e-05	0.000791	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CB—malignant glioma	7.37e-05	0.000791	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS2—malignant glioma	7.3e-05	0.000784	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS2—malignant glioma	7.3e-05	0.000784	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CAV1—malignant glioma	7.17e-05	0.00077	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CG—malignant glioma	7.1e-05	0.000763	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTEN—malignant glioma	7e-05	0.000752	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPARG—malignant glioma	6.86e-05	0.000736	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CB—malignant glioma	6.83e-05	0.000733	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTEN—malignant glioma	6.82e-05	0.000732	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTEN—malignant glioma	6.82e-05	0.000732	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CG—malignant glioma	6.81e-05	0.000731	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS2—malignant glioma	6.76e-05	0.000726	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPARG—malignant glioma	6.57e-05	0.000706	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CG—malignant glioma	6.53e-05	0.000701	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTEN—malignant glioma	6.37e-05	0.000684	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTEN—malignant glioma	6.37e-05	0.000684	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CAV1—malignant glioma	6.3e-05	0.000677	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPARG—malignant glioma	6.3e-05	0.000677	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CD—malignant glioma	6.25e-05	0.000671	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CD—malignant glioma	5.99e-05	0.000643	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTEN—malignant glioma	5.9e-05	0.000633	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CG—malignant glioma	5.74e-05	0.000616	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CD—malignant glioma	5.74e-05	0.000616	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPARG—malignant glioma	5.54e-05	0.000595	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CB—malignant glioma	5.44e-05	0.000585	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS2—malignant glioma	5.39e-05	0.000579	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CB—malignant glioma	5.22e-05	0.00056	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS2—malignant glioma	5.17e-05	0.000555	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CD—malignant glioma	5.05e-05	0.000542	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CB—malignant glioma	5e-05	0.000537	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS2—malignant glioma	4.96e-05	0.000532	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CA—malignant glioma	4.94e-05	0.00053	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CA—malignant glioma	4.81e-05	0.000517	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CA—malignant glioma	4.81e-05	0.000517	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—COX8A—malignant glioma	4.81e-05	0.000516	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTEN—malignant glioma	4.7e-05	0.000505	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTEN—malignant glioma	4.51e-05	0.000484	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CA—malignant glioma	4.49e-05	0.000482	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CA—malignant glioma	4.49e-05	0.000482	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CB—malignant glioma	4.4e-05	0.000472	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS2—malignant glioma	4.36e-05	0.000468	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTEN—malignant glioma	4.32e-05	0.000464	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CA—malignant glioma	4.16e-05	0.000447	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ASMT—malignant glioma	4.09e-05	0.000439	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AKT1—malignant glioma	4.03e-05	0.000433	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AKT1—malignant glioma	3.93e-05	0.000422	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AKT1—malignant glioma	3.93e-05	0.000422	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—BCAN—malignant glioma	3.85e-05	0.000413	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTEN—malignant glioma	3.8e-05	0.000408	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AKT1—malignant glioma	3.67e-05	0.000394	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AKT1—malignant glioma	3.67e-05	0.000394	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AKT1—malignant glioma	3.4e-05	0.000365	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CA—malignant glioma	3.32e-05	0.000356	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CA—malignant glioma	3.18e-05	0.000342	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—IDH2—malignant glioma	3.1e-05	0.000333	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CA—malignant glioma	3.05e-05	0.000328	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.91e-05	0.000313	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AKT1—malignant glioma	2.71e-05	0.000291	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CA—malignant glioma	2.68e-05	0.000288	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—IDH1—malignant glioma	2.67e-05	0.000286	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AKT1—malignant glioma	2.6e-05	0.000279	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SPHK1—malignant glioma	2.58e-05	0.000277	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.53e-05	0.000271	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AKT1—malignant glioma	2.49e-05	0.000268	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AKT1—malignant glioma	2.19e-05	0.000235	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTT1—malignant glioma	2.04e-05	0.000219	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS1—malignant glioma	1.91e-05	0.000206	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—BCHE—malignant glioma	1.78e-05	0.000191	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.76e-05	0.000189	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTP1—malignant glioma	1.42e-05	0.000152	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CAT—malignant glioma	1.38e-05	0.000148	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOR1—malignant glioma	1.3e-05	0.00014	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CAV1—malignant glioma	1.06e-05	0.000114	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CG—malignant glioma	9.66e-06	0.000104	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARG—malignant glioma	9.33e-06	0.0001	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CD—malignant glioma	8.5e-06	9.12e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CB—malignant glioma	7.41e-06	7.95e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS2—malignant glioma	7.34e-06	7.88e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTEN—malignant glioma	6.4e-06	6.87e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.51e-06	4.85e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKT1—malignant glioma	3.69e-06	3.96e-05	CbGpPWpGaD
